Coronary artery blood flow: Physiologic and pathophysiologic regulation

Clinical Cardiology

Volumn 22, Issue 12, 1999, Pages 775-786

  Feliciano, Lillybeth ^a   Henning, Robert J ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c James A Haley Veterans Hospital   (United States)

Author keywords

Adenosine; Atherosclerosis; Autoregulation; Coronary blood flow; Hyperlipidemia; Nitric oxide; Regulation of coronary blood flow; Vascular endothelium

Indexed keywords

ADENOSINE; NITRIC OXIDE;

CARDIOVASCULAR AUTOREGULATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HYPERLIPIDEMIA; HYPERTENSION; OXYGEN SUPPLY; PATHOPHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0032705849     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960221205     Document Type: Review

References (143)

1. Yang SS, Bentivoglio LG, Maranhao V, Goldberg H: Assessment of ventricular function. In From Cardiac Catheterization Data to Hemodynamic Parameters, p. 207-208. Philadelphia: F.A. Davis Company, 1988
2. Rooke GA, Feigl EO: Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 1982;50:273-286
3. Rubio R, Berne RM: Regulation of coronary blood flow. Prog Cardiovasc Dis 1975;18(2):105-122
4. Marcus M: Metabolic regulation of coronary blood flow. In The Coronary Circulation in Health and Disease, p. 65-92. New York: McGraw Hill, 1983
5. Kelley KO, Feigl EO: Segmental alpha-receptor-mediated vaso-constriction in the canine coronary circulation. Circ Res 1978; 43:908-917
6. Chilian WM, Kuo L, DeFily DV, Jones CJH, Davis MJ: Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions. Eur Heart J 1993;14(suppl I):55-59
7. Chilian WM, Layne SM, Klausner EC, Eastham CL, Marcus ML: Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol 1989;256:H383-390
8. Braunwald E, Sobel BE: Coronary blood flow and myocardial ischemia. In Heart Disease, A Textbook of Cardiovascular Medicine, 4th Ed. (Ed. Braunwald E), p. 1161-1199. Philadelphia: W.B. Saunders, 1992
9. Schlant RC, Sonnenblick EH: Pathophysiology of heart failure. In The Heart (Eds. Schlant RC, Alexander RW), p. 528-529. New York: McGraw-Hill, Inc., 1994
10. National Heart, Lung, and Blood Institute: Morbidity from Coronary Heart Disease in the United States. NHLBI Data Fact Sheet, June 1990
11. Kelm M, Schrader J: Control of coronary vascular tone by nitric oxide. Circ Res 1990;66:1561-1575
12. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO: Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995;92:320-326
13. Jones CJH, Kuo L, Davis MJ, DeFily DV, Chilian WM: Role of nitric oxide in the coronary microvascular response to adenosine and increased metabolic demand. Circulation 1995;91:1807-1813
14. Losano G, Pagliaro P, Gattullo D, Marsh NA: Control of coronary blood flow by endothelial release of nitric oxide. Clin Experim Pharmacol Physiol 1994;21:783-789
15. Kuo L, Davis MI, Chilian WM: Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 1990; 259:H1063-1070
16. Jones CJH, Kuo L. Davis MJ, Chilian WM: Regulation of coronary blood flow: Coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 1995;29(5):585-596
17. Liao JC, Kuo L: Interaction between adenosine and flow-induced dilation in coronary microvascular network. Am J Physiol 1997; 272:H1571-1581
18. Drexler H, Zeiher AM, Wollschlager H, Meinertz T, Just H, Bonzel T: Flow-dependent coronary artery dilation in humans. Circulation 1989;80:466-474
19. Kuo L, Chilian WM, Davis MJ: Interaction of pressure-and flow-induced responses in porcine coronary resistance vessels. Am J Physiol 1991;261:H1706-1715
20. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376
21. Kuo L, Davis MJ, Cannon MS, Chilian WM: Pathophysiological consequences of atherosclerosis extend to the microcirculation. Circ Res 1992;70:465-476
22. Pohl U, Busse R, Kuon E, Bassenge E: Pulsatile perfusion stimulates the release of endothelial autacoids. J Appl Cardiol 1986; 1:215-235
23. Shen J, Luscinskas FW, Connolly A, Forbes Dewey C, Gimbrone MA: Fluid shear stress modulates cytosolic free calcium in vascular endothelial cells. Am J Physiol 1992;262:C384-C390
24. Altman JD, Kinn J, Duncker JK, Bache RJ: Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in dog. Cardiovasc Res 1994;28:119-124
25. Gattullo D, Pagliaro P, Linden RJ, Merletti, Losano G: The role of nitric oxide in the initiation and in the duration of some vasodilator responses in the coronary circulation. Pflugers Arch - Eur J Physiol 1995;430:96-104
26. Hintze TH, Vatner SF: Reactive dilation of large coronary arteries in conscious dogs. Circ Res 1984;54:50-57
27. Lamontagne D, Pohl U, Busse R: Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 1992;70:123-130
28. Bassenge E: Control of coronary blood flow by autacoids. Basic Res Cardiol 1995;90:125-141
29. Parent R, al-Obaidi M, Lavall M: Nitric oxide formation contributes to α-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 1993;73:241-251
30. Miller WL, Belardinelli L, Bacchus A, Foley DH, Rubio R, Berne RM: Canine myocardial adenosine and lactate production, oxygen consumption, and coronary blood flow during stellate ganglia stimulation. Circ Res 1979;45(6):708-718
31. Van Winkle DM, Feigl EO: Acetylcholine causes coronary vasodilation in dogs and baboons. Circ Res 1989;65:1580-1593
32. Broten TP, Miyashiro JK, Moncada S, Feigl EO: Role of endothelium-derived relaxing factor in parasympathetic coronary vasodilation. Am J Physiol 1992;262:H1579-H1584
33. Pelc LR, Gross GJ, Warltier DC: Changes in regional myocardial perfusion by muscarinic receptor subtypes in dogs. Cardiovasc Res 1986;20(7):482-489
34. Ren LM, Nakane T, Chiba S: Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries. J Cardiovasc Pharmacol 1993;22:841-846
35. Muller JM, Davis MJ, Chilian WM: Integrated regulation of pressure and flow in the coronary microcirculation. Cardiovasc Res 1996;32:668-678
36. 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 1993;87:1264-1275
37. 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol 1986;88:767-777
38. Nagao T, Vanhoutte PM: Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Respir Cell & Mol BioL 1993(8):1-6
39. Mehta J: Endothelium, coronary vasodilation, and organic nitrates. Am Heart J 1995;129:382-391
40. Dinerman JL, Mehta JL: Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol 1990;16: 207-222
41. Bennet BM, Waldman SA: Cyclic nucleotides and protein phosphorylalion in vascular smooth muscle relaxation, In Physiology and Pathophysiology of the Heart (Ed. N. Sperelakis), p. 975-998. Norwell, Mass.: Kluwer Academic Publishers, 1995
42. Sperelakis N, Xiong G, Haddad H, Masuda H: Regulation of slow calcium channels of myocardial cells and vascular smooth muscle cells by cyclic nucleotides and phosphorylation. Mol Cell Biochem 1994;140(2):103-117
43. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415
44. Rubanyi GM, Polokoff MA: Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46(3):328-415
45. Luscher TF, Wenzel RR, Noll G: Local regulation of the coronary circulation in health and disease: Role of nitric oxide and endothelin. Eur Heart J 1995;16(suppl C):51-58
46. Hori M, Kitakaze M: Adenosine, the heart, and coronary circulation. Hypertension 1991;18:565-574
47. Bache RJ, Dai XZ, Schwartz JS, Homans DC: Role of adenosine in coronary vasodilation during exercise. Circ Res 1988;62:846-853
48. Berne RM: The role of adenosine in the regulation of coronary blood flow. Circ Res 1980;47(6):807-813
49. + channel blocker, inhibits coronary autoregulation in anesthetized dogs. Circ Res 1993;73:771-776
50. Kusachi S, Thompson RD, Olsson RA: Ligand selectivity of dog adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. J Pharmacol Exp Ther 1983;227:316-321
51. Bruns RF, Lu GH, Pugsley TA: Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol 1986;29:331-346
52. Broten TP, Feigl EO: Role of myocardial oxygen and carbon dioxide in coronary autoregulation. Am J Physiol 1992;262:H1231-H1237
53. DeFily DV, Chilian WM: Coronary microcirculation: Autoregulation and metabolic control. Basic Res Cardiol 1995;90:112-118
54. Jones CJH, Kuo L, Davis MJ, Chilian WM: Distribution and control of coronary microvascular resistance. In Interactive Phenomena in the Cardiac System (Eds. Sideman S, Beyar R), p. 181-188. New York: Plenum Press, 1993
55. Jones CJH, Kuo L, Davis MJ, Chilian WM: Myogenic and flow-dependent control mechanisms in the coronary circulation. Basic Res Cardiol 1993;88:2-10
56. Kuo L, Davis MI, Chilian WM: Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am J Physiol 1988;255:H1558-H1562
57. Davis MJ, Donovitz JA, Hood JD: Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells. Am J Physiol 1992;262:C1083-C1088
58. Meininger GA, Davis MJ: Cellular mechanisms involved in the myogenic response. Am J Physiol 1992;263:H647-H659
59. + channels in arterial smooth muscle. Science 1989;254:177-180
60. Komaru T, Kanatsuka H, Dellsperger K, Takishima T: The role of ATP-sensitive potassium channels in regulating coronary microcirculation. Biorheology 1993;30:371-380
61. Dole WP: Autoregulation of the coronary circulation. Prog Cardiovasc Dis 1987;29(4):293-323
62. Smith TP Jr, Canty JM Jr: Modulation of coronary autoregulatory responses by nitric oxide: Evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 1993;73:232-240
63. Boatwright RB, Downey HF, Bashour FA, Crystal GJ: Transmural variation in autoregulation of coronary blood flow in hyperperfused canine myocardium. Circ Res 1980;47:599-609
64. Dole WP, Montville WJ, Bishop VS: Dependency of myocardial reactive hyperemia on coronary artery pressure in the dog. Am J Physiol 1981;240(5):H709-H715
65. Kanatsuka H, Lamping KG, Eastham CL, Marcus ML: Heterogeneous changes in epimyocardial microvascular size during graded coronary stenosis. Circ Res 1990;66:389-396
66. Chilian WM, Layne SM: Coronary microvascular responses to reductions in perfusion pressure: Evidence for persistent arteriolar vasomotor tone during coronary hypoperfusion. Circ Res 1990;66: 1227-1238
67. Feigl EO: Coronary physiology. Physiol Rev 1983;63:1-205
68. Ueeda M, Silvia SK, Olsson RA: Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res 1992;70:1296-1303
69. Chilian WM, Layne SM, Eastham CL, Marcus ML: Heterogeneous microvascular coronary α-adrenergic vasoconstriction. Circ Res 1989;64:376-388
70. Marcus ML: Neural control of the coronary circulation. In The Coronary Circulation in Health and Disease, Chapter 6, p. 129-146. New York: McGraw-Hill, 1983
71. 2-adrenoceptors in conscious dogs (Part 2 of 2). Am J Physiol 1987;253:H388-H393
72. Marcus ML: Humoral control of the coronary circulation. In The Coronary Circulation in Health and Disease. Chapter 8, p. 155-187. New York: McGraw-Hill, 1987
73. Kelley KO, Feigl EO: Segmental α-receptor mediated vasoconstriction in the canine coronary circulation. Circ Res 1978;43(6): 908-917
74. Chen DG, Dai X, Bache RJ: Post-synaptic adrenoreceptor-mediated vasoconstriction in coronary and femoral vascular beds. Am J Physiol 1988;254:H984-H992
75. Young MA, Vatner SF: Regulation of large coronary arteries. Circ Res 1986;59(6):579-596
76. 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 1993;87:1264-1274
77. 2-adrenergic receptors in the coronary microcirculation. Circulation 1991;84: 2108-2122
78. 1 adrenoceptors predominate in vasodilation. J Pharmacol Exp Ther 1988;245: 936-943
79. Murphree SS, Saffitz JE: Delineation of the distribution of α-adrenergic receptor subtypes in canine myocardium. Circ Res 1988;63: 117-125
80. Duncker DJ, Stubenitsky R, Verdouw PD: Autonomic control of vasomotion in the procine coronary circulation during treadmill exercise. Evidence for feed-forward β-adrenergic control. Circ Res 1998;82:1312-1322
81. Jaiswal N, Malik KU: Methoctramine, a cardioselective antagonist: Muscarinic receptor mediating prostaglandin synthesis in isolated rabbit heart. Eur J Pharmacol 1991;192(1):63-70
82. Hoover DB, Neely DA: Differentiation of muscarinic receptors mediating negative chronotropic and vasoconstrictior responses to acetylcholine in isolated rat hearts. J Pharmacol Exp Ther 1997; 282:1337-1344
83. 3-muscarinic antagonism. Anesth Analg 1993;76: 382-390
84. Su N, Narayanan N: Age related alterations in cholinergic but not α adrenergic response of rat coronary vasculature. Cardiovasc Res 1993;27:284-290
85. Forssman WG, Triepel J, Daffner C, Heym CH: Vasoactive intestinal peptide in the heart. Ann NY Acad Sci 1988;527:405-420
86. Gu J, Polak JM, Adrian TE, Tatemoto K, Allen JM, Bloom SR: Neuropeptide tyrosine (NPY) - a major cardiac neuropeptide. Lancet 1983 I(8332):1008-1010
87. Franco-Cereceda A, Lundberg JM: Potent effects of neuropeptide Y and calcitonin gene-related peptide on human coronary vascular tone in vitro. Acta Physiol Scand 1987;131:159-160
88. Huang M, Rorstad OP: VIP receptors in mesenteric and coronary arteries: A radioligand binding study. Peptides 1987;8(3):477-485
89. Chujo M, Mori H, Tanaka E, Nakazawa H, Okino H: Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction. Cardiovasc Res 1994;28:917-922
90. Rudehill A, Sollevi A, Franco-Cereceda A, Lundberg JM: Neuropeptide Y (NPY) and the pig heart: Release and coronary vasoconstrictor effects. Peptides 1986;7:821-826
91. Feliciano L, Henning RJ: Vagal nerve stimulation during muscarinic and beta-adrenergic blockade causes significant coronary artery dilation. J Autonom Nerv Syst 1998;68:78-88
92. Feliciano L, Henning RJ: Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow. Cardiovasc Res 1998;40:45-55
93. Aizawa Y, Murata M, Hayashi M, Funazaki T, Ito S, Shibata A: Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery. Jpn Circ J 1985;49:584-588
94. Weihe E, Reinecke M: Peptidergic innervation of the mammalian sinus nodes: Vasoactive intestinal polypeptide, neurotensin, substance P. Neurosci Lett 1981;26(3):283-288
95. Brum JM, Bove AA, Sufan Q, Reilly W, Go Vay LW: Action and localization of vasoactive intestinal peptide in the coronary circulation: Evidence for nonadrenergic, noncholinergic coronary regulation. J Am Coll Cardiol 1986;7(20):406-413
96. Popma JJ, Smitherman TC, Bedotto JB, Eichhorn EJ, Said SI, Dehmer GJ: Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide. J Cardiovasc Pharmacol 190;16(6): 1000-1006
97. Alexander RW, Pratt CM, Roberts R: Diagnosis and management of patients with acute myocardial infarction. In Hurst's The Heart (Eds. Alexander RW, Schlant RC, Fuster V), p. 1345-1434. New York: McGraw-Hill, 1988
98. Drexler H, Zeiher AM, Meinzer K, Just H: Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991;338:1546-1550
99. Zeiher AM, Drexler H, Wollschalger H, Just H: Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-1992
100. Treasure CB, Klein JL, Vita JA, Manoukian SU, Remwick G, Selwyn A, Ganz P, Alexander W: Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87:86-93
101. Treasure CB, Vita JA, Cox DA: Endothelium-dependent dilation of the coronary microvasculture is impaired in dilated cardiomyopathy. Circulation 1990;81:772-779
102. Liao JK: Nitric oxide and vascular disease. Cardiol Rounds 1998; 2(5):1-7
103. Zeiher AM, Drexler H, Wollschlager H, Just H: Modulation of coronary vasomotor tone: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83:391-401
104. Chilian WM, Dellsperger KC, Layne SM, Eastham CL, Armstrong MA, Marcus ML, Heistad DD: Effects of atherosclerosis on the coronary microcirculation. Am J Physiol 1990;258:H529-H539
105. Selke FW, Armstrong ML, Harrison DG: Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 1990;81:1586-1593
106. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD: Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988;63:903-910
107. Luscher TF, Noll G: Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol 1994;24(suppl 3):S16-S26
108. Strauer BE: The concept of coronary flow reserve. J Cardiovasc Pharmacol 1992;19(suppl. 5):S67-S80
109. Bradley AJ, Alpert JS: Coronary flow reserve. Am Heart J 1991; 122(4):1116-1128
110. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M; Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996;94(12): 3232-3238
111. Harrison DG, Marcus ML, Dellsperger KC, Lamping KG, Tomanek RJ: Pathophysiology of myocardial perfusion in hypertension. Circulation 1991;83(suppl III):III-14-III-18.
112. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E: Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345-2352
113. Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO: Nitric oxide activity in atherosclerotic human coronary circulation. J Am Coll Cardiol 1997;29(2):308-317
114. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH: Low basal and stimulated release of nitric oxide in atherosclerotic epicardial vessels. Lancet 1990;336:897-900
115. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum J, Steinberg D: Gene expression in macrophage-rich human atherosclerotic lesions. J Clin Invest 1991;87:1146-1152
116. Tanner FC, Noll G, Boulanger CM, Luscher TF: Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991;83:2012-2020
117. Flavahan NA: Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF /nitric oxide activity. Circulation 1992;85(5):1927-1938
118. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809
119. 2. Circulation 1994; 89:2266-2272
120. Abrams J: Role of endothelial dysfunction in coronary artery disease. Am J Cardiol 1997;79(12B):2-9
121. Steinberg D: Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062-1071
122. Kinlay S, Ganz. P: Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 1997;80 (9A):111-161
123. Kuo L, Davis MJ, Cannon MS, Chilian WM: Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine. Circ Res 1992;70:465-476
124. Tarry WC, Makhoul RG: L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler Thromb 1994;14:938-943
125. Yasue H, Omote S, Takizawa A, Nagano M: Coronary arterial spasm in ischemic heart disease and its pathogenesis. Circ Res 1983;52(suppl I):147-152
126. Maseri A, Severi S, De Nes MD, L'Abbate A, Chierchia S, Marzilli M, Ballestra AM, Parodi O, Biagini A, Dislante A: "Variant" angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia. Am J Cardiol 1978;42:1019-1035
127. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Myotoyama T, Inobe Y, Kawano H: Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-272
128. Maseri A: Role of coronary artery spasm in symptomatic and silent myocardial ischemia. J Am Coll Cardiol 1987;9(2):249-262
129. Kugiyama, K, Ohgushi M, Motoyama T, Sugiyama, S, Ogawa H, Yoshimura M, Inobe Y, Hirashima O, Kawano H, Soejima H, Yasue H: Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997;30(4):920-926
130. Shepherd JT, Katusic ZS, Vedernikov Y, Vanhoutte PM: Mechanisms of coronary vasospasm: Role of the endothelium. J Mol Cell Cardiol 1991:23(suppl I):125-131
131. Cohen RA: Platelet-induced neurogenic coronary arterial contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine. J Clin Invest 1985;75:286-293
132. Harrison DG, Treasure CB, Mugge A, Dellsperger KC, Lamping KC: Hypertension and the coronary circulation. With special attention to endothelial regulation. Am J Hypertens 1991;4:454S-459S
133. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003
134. Brush JE, Cannon RO, Schenke BA, Bonow RO, Leon MB, Maron BJ, Epstein SE: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-1307
135. Brush JE, Faxon DP, Salmon S, Jacobs AK, Ryan TJ: Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992;19(4):809-815
136. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG: Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995;95:187-194
137. Raman VK, Lee Y-A, Lindpaintner K: The cardiac renin-angio-tensin-aldosterone system and hypertensive cardiac hypertrophy. Am J Cardiol 1995;76:18D-23D
138. Chobanian AV, Lichtenstein AH, Nilakhe V, Haudenschild CC, Drago R, Nickerson C: Influence on aortic atherosclerosis in the Watanabe rabbit. Hypertension 1989;14:203-209
139. Tanaka M, Fujiwara H, Onodera T, Wu DJ. Matsuda M, Hamashima Y, Kawai C: Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987;75: 1130-1139
140. Suzuki M, Ikebuchi M, Shinozaki K, Hara Y, Tsushima M, Matsuyama T, Harano Y: Mechanism and clinical implication of insulin resistance syndrome. Diabetes 1996;45(suppl 3):S52-S54
141. Mancini GBJ: Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease. Am J Med 1998;105(1A):40S-47S
142. Weber MA: Role of hypertension in coronary artery disease. Am J Nephrol 1996;16:210-216
143. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992;5:95-110